Assessment of receptor activator of nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG) in lymphoma patients

被引：0
|
作者：
Ayoub, M. [1 ]
Gadallah, H. [1 ]
Hegab, H. [1 ]
Khattab, D. [2 ]
Mostafa, N. [1 ]
机构：
[1] Ain Shams Univ, Internal Med Hematol Unit, Cairo, Egypt
[2] Ain Shams Univ, Dept Clin Pathol, Cairo, Egypt
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(10)70714-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
43
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [1] IDENTIFICATION OF RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-kappa B LIGAND(RANKL) AND OSTEOPROTEGERIN(OPG) IN AMELOBLASTOMA
    Ha, Woo-Hun
    Hwang, Dae-Seok
    Kim, Yong-Deok
    Shin, Sang-Hun
    Kim, Uk-Kyu
    Kim, Jong-Ryoul
    Chung, In-Kyo
    JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS, 2007, 33 (02) : 94 - 102
  • [2] Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: Are they of any help?
    Wagner, Doris
    Fahrleitner-Pammer, Astrid
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2010, 160 (17-18) : 452 - 457
  • [3] ROLE OF RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B LIGAND (RANKL) AND OSTEOPROTEGERIN (OPG) IN PERIODONTAL BONE DESTRUCTION: A REVIEW
    Moon, Ninad
    Khan, Mohd. Inayatulla
    Moon, Archana
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2014, 3 (18): : 4781 - 4785
  • [4] Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: Are they of any help?Osteoprotegerin (OPG) und Receptor Activator for Nuclear Factor kappaB Ligand (RANKL) Bestimmung im Serum: Sinn oder Unsinn?
    Doris Wagner
    Astrid Fahrleitner-Pammer
    Wiener Medizinische Wochenschrift, 2010, 160 (17-18) : 452 - 457
  • [5] Study of the serum level of receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin (OPG) in patients with rheumatoid arthritis
    Wagdy, E.
    Moghazy, T. F.
    Ragab, W. S.
    Aref, T. Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 372 - 372
  • [6] Receptor activator of nuclear factor κB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis
    Grimaud, E
    Soubigou, L
    Couillaud, S
    Coipeau, P
    Moreau, A
    Passuti, N
    Gouin, F
    Redini, F
    Heymann, D
    AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (05): : 2021 - 2031
  • [7] RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B LIGAND (RANKL)/RANK AND OSTEOPROTEGERIN (OPG) PATHWAY ACTIVATION IN SJOGREN'S SYNDROME
    Skarlis, Charalampos
    Palli, Eleni
    Nezos, Adrianos
    Mavragani, Clio
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1549 - 1549
  • [8] RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA-B LIGAND (RANKL) AND OSTEOPROTEGERIN (OPG) IN RADICULAR CYSTS, DENTIGEROUS CYSTS AND HEALTHY VOLUNTEERS
    Pechalova, Petia F.
    Poriazova, Elena G.
    Pavlov, Nikolai V.
    Gospodinov, Dimitar L.
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2016, 69 (03): : 385 - 392
  • [9] Osteoblasts respond to mild heat stress by a change in osteoprotegerin (OPG) and receptor activator of nuclear factor-kappa B ligand (RANKL) ratio
    Meghji, S.
    Ong, S. T.
    Maddi, A.
    Vinayahan, G.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (07) : 1155 - 1155
  • [10] The Effect of Osteoprotegerin (OPG)/Receptor Activator of Nuclear Factor-κB Ligand (RANKL)/Receptor Activator of Nuclear Factor-κB (RANK) on Aortic Valve Calcified
    Luo, Wei
    Wang, Jing
    Yang, Xia
    Li, Junshan
    Song, Yanqiu
    Cong, Hongliang
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2024, 54 (05): : 633 - 642
12345